Industry Briefs


Jury Rules Against Micromass in Triple Quad Patent Dispute with ABI/MDS Sciex

 Following a federal jury’s decision against Micromass in its patent dispute with Applied Biosystems and MDS Sciex over triple quadrupole mass spectrometry technology, Micromass has decided to postpone the launch of the Quattro Ultima Pt, its top-of-the-line triple quadrupole instrument, the company said last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.